Global Gastric Cancer Patient Insights and Epidemiology - 2016

  • ID: 3692139
  • Report
  • Region: Global
  • 110 pages
  • Epipatients
1 of 3
The latest survey Global Gastric Cancer Patient Insights and Epidemiology – 2016, provides insights into total Gastric Cancer patients on drug therapies in top 7 markets, Gastric Cancer treatable patients, and Gastric Cancer epidemiology in top 7 markets. Epipatients conducted an online survey with Gastric Cancer specialists, oncologists, and Gastric Cancer patients to identify the Gastric Cancer patients in top 7 markets who were treated by drug therapies. The research also identifies total Gastric Cancer patients’ on drug therapies by Gastric Cancer stages.
Gastric cancer patients were on chemotherapies and targeted therapies as a part of their treatment. This study accurately determines and forecast Gastric Cancer patients who were on drug therapies in a given year. This research also provides insights into Gastric Cancer epidemiology including Gastric Cancer incidence and Gastric Cancer prevalence by Gastric Cancer stages I-IV.

Key Questions Answered:
- Countries: US, Japan, Germany, France, Italy, Spain, UK
- Gastric Cancer Incidence in top 7 markets by staging – Stage I, Stage II, Stage III, and Stage IV
- Gastric Cancer Prevalence in top 7 markets (10-year) by staging – Stage I, Stage II, Stage III, and Stage IV
- Gastric Cancer Treatable Patients in top 7 markets by staging – Stage I, Stage II, Stage III, and Stage IV
- Gastric Cancer Patients on drug therapies by stages – Stage I, Stage II, Stage III, and Stage IV
- Base Year – 2015, Historic from 2010 and forecast to 2025

Key Benefits:
This research will help analysts, healthcare providers, pharmaceutical companies, epidemiologists, clinical research organizations, universities, government agencies, and insurers to determine their study population. This research will help executives estimate Gastric Cancer market potential, Gastric Cancer drug therapies market potential, assess unmet need, patient share, market share, develop forecasting models, and build patient-based health management frameworks. The data presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Methodology
2. Gastric Cancer Patients Globally by Stages
2.1. Incidence
2.2. Prevalence
2.3. Treatable Patients
2.4. Patients on drug therapies
3. Gastric Cancer Patients in Germany by Stages
3.1. Incidence
3.2. Prevalence
3.3. Treatable Patients
3.4. Patients on drug therapies
4. Gastric Cancer Patients in France by Stages
4.1. Incidence
4.2. Prevalence
4.3. Treatable Patients
4.4. Patients on drug therapies
5. Gastric Cancer Patients in Italy by Stages
5.1. Incidence
5.2. Prevalence
5.3. Treatable Patients
5.4. Patients on drug therapies
6. Gastric Cancer Patients in Spain by Stages
6.1. Incidence
6.2. Prevalence
6.3. Treatable Patients
6.4. Patients on drug therapies
7. Gastric Cancer Patients in UK by Stages
7.1. Incidence
7.2. Prevalence
7.3. Treatable Patients
7.4. Patients on drug therapies
8. Gastric Cancer Patients in Japan by Stages
8.1. Incidence
8.2. Prevalence
8.3. Treatable Patients
8.4. Patients on drug therapies
9. Gastric Cancer Patients in US by Stages
9.1. Incidence
9.2. Prevalence
9.3. Treatable Patients
9.4. Patients on drug therapies
10. Glossary

1. Gastric Cancer Incidence by Stages, Global, 2010 - 2025
2. Gastric Cancer Prevalence by Stages, Global, 2010 - 2025
3. Gastric Cancer Treatable Patients by Stages, Global, 2010 - 2025
4. Total Gastric Cancer Patients on drug therapies by Stages, Global, 2010 – 2025
5. Gastric Cancer Incidence by Stages, Germany, 2010 - 2025
6. Gastric Cancer Prevalence by Stages, Germany, 2010 - 2025
7. Gastric Cancer Treatable Patients by Stages, Germany, 2010 - 2025
8. Total Gastric Cancer Patients on drug therapies by Stages, Germany, 2010 - 2025
9. Gastric Cancer Incidence by Stages, France, 2010 - 2025
10. Gastric Cancer Prevalence by Stages, France, 2010 - 2025
11. Gastric Cancer Treatable Patients by Stages, France, 2010 - 2025
12. Total Gastric Cancer Patients on drug therapies by Stages, France, 2010 - 2025
13. Gastric Cancer Incidence by Stages, Italy, 2010 - 2025
14. Gastric Cancer Prevalence by Stages, Italy, 2010 - 2025
15. Gastric Cancer Treatable Patients by Stages, Italy, 2010 - 2025
16. Total Gastric Cancer Patients on drug therapies by Stages, Italy, 2010 - 2025
17. Gastric Cancer Incidence by Stages, Spain, 2010 - 2025
18. Gastric Cancer Prevalence by Stages, Spain, 2010 - 2025
19. Gastric Cancer Treatable Patients by Stages, Spain, 2010 - 2025
20. Total Gastric Cancer Patients on drug therapies by Stages, Spain, 2010 - 2025
21. Gastric Cancer Incidence by Stages, UK, 2010 - 2025
22. Gastric Cancer Prevalence by Stages, UK, 2010 - 2025
23. Gastric Cancer Treatable Patients by Stages, UK, 2010 - 2025
24. Total Gastric Cancer Patients on drug therapies by Stages, UK, 2010 – 2025
25. Gastric Cancer Incidence by Stages, Japan, 2010 - 2025
26. Gastric Cancer Prevalence by Stages, Japan, 2010 - 2025
27. Gastric Cancer Treatable Patients by Stages, Japan, 2010 - 2025
28. Total Gastric Cancer Patients on drug therapies by Stages, Japan, 2010 – 2025
29. Gastric Cancer Incidence by Stages, US, 2010 - 2025
30. Gastric Cancer Prevalence by Stages, US, 2010 - 2025
31. Gastric Cancer Treatable Patients by Stages, US 2010 - 2025
32. Total Gastric Cancer Patients on drug therapies by Stages, US, 2010 - 2025

1. Gastric Cancer Incidence, Global, 2010 – 2025
2. Gastric Cancer Incidence – Stage I, Global, 2010 – 2025
3. Gastric Cancer Incidence – Stage II, Global, 2010 - 2025
4. Gastric Cancer Incidence – Stage III, Global, 2010 - 2025
5. Gastric Cancer Incidence – Stage IV, Global, 2010 – 2025
6. Gastric Cancer Prevalence, Global, 2010 - 2025
7. Gastric Cancer Prevalence – Stage I, Global, 2010 – 2025
8. Gastric Cancer Prevalence – Stage II, Global, 2010 - 2025
9. Gastric Cancer Prevalence – Stage III, Global, 2010 - 2025
10. Gastric Cancer Prevalence – Stage IV, Global, 2010 - 2025
11. Gastric Cancer Treatable Patients, Global, 2010 - 2025
12. Gastric Cancer Treatable Patients – Stage I, Global, 2010 – 2025
13. Gastric Cancer Treatable Patients – Stage II, Global, 2010 - 2025
14. Gastric Cancer Treatable Patients – Stage III, Global, 2010 - 2025
15. Gastric Cancer Treatable Patients – Stage IV, Global, 2010 - 2025
16. Gastric Cancer Patients on drug therapies, Global, 2010 - 2025
17. Total Gastric Cancer Patients on drug therapies – Stage I, Global, 2010 – 2025
18. Total Gastric Cancer Patients on drug therapies – Stage II, Global, 2010 – 2025
19. Total Gastric Cancer Patients on drug therapies – Stage III, Global, 2010 – 2025
20. Total Gastric Cancer Patients on drug therapies – Stage IV, Global, 2010 – 2025
21. Gastric Cancer Incidence by Stages, Germany, 2010 – 2025
22. Gastric Cancer Prevalence by Stages, Germany, 2010 – 2025
23. Gastric Cancer Treatable Patients by Stages, Germany, 2010 – 2025
24. Gastric Cancer Patients on drug therapies, Germany, 2010 - 2015
25. Gastric Cancer Incidence by Stages, France, 2010 – 2025
26. Gastric Cancer Prevalence by Stages, France, 2010 – 2025
27. Gastric Cancer Treatable Patients by Stages, France, 2010 – 2025
28. Gastric Cancer Patients on drug therapies, France, 2010 – 2025
29. Gastric Cancer Incidence by Stages, Italy, 2010 – 2025
30. Gastric Cancer Prevalence by Stages, Italy, 2010 – 2025
31. Gastric Cancer Treatable Patients by Stages, Italy, 2010 – 2025
32. Gastric Cancer Patients on drug therapies, Italy, 2010 – 2025
33. Gastric Cancer Incidence by Stages, Spain, 2010 – 2025
34. Gastric Cancer Prevalence by Stages, Spain, 2010 – 2025
35. Gastric Cancer Treatable Patients by Stages, Spain, 2010 – 2025
36. Gastric Cancer Patients on drug therapies, Spain, 2010 - 2015
37. Gastric Cancer Incidence by Stages, UK, 2010 – 2025
38. Gastric Cancer Prevalence by Stages, UK, 2010 – 2025
39. Gastric Cancer Treatable Patients by Stages, UK, 2010 – 2025
40. Gastric Cancer Patients on drug therapies, UK, 2010 – 2025
41. Gastric Cancer Incidence by Stages, Japan, 2010 – 2025
42. Gastric Cancer Prevalence by Stages, Japan, 2010 – 2025
43. Gastric Cancer Treatable Patients by Stages, Japan, 2010 – 2025
44. Gastric Cancer Patients on drug therapies, Japan, 2010 – 2025
45. Gastric Cancer Incidence by Stages, US, 2010 – 2025
46. Gastric Cancer Prevalence by Stages, US, 2010 – 2025
47. Gastric Cancer Treatable Patients by Stages, US, 2010 – 2025
48. Gastric Cancer Patients on drug therapies, US, 2010 - 2015
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll